Fluticasone reduces CRP in COPD.
Virchow
J Christian
JC
D000730:Androstadienes / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000150:complications / Q000378:metabolism; D002097:C-Reactive Protein / Q000187:drug effects* / Q000378:metabolism; D003324:Coronary Artery Disease / Q000150:complications / Q000378:metabolism; D000068298:Fluticasone; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood* / Q000150:complications / Q000188:drug therapy*; D018570:Risk Assessment; D016896:Treatment Outcome
D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D002097:C-Reactive Protein; D000068298:Fluticasone